Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome.

No abstract is available for this paper.

• Publication year

  1973

• Venue

  The Lancet

• Publication date

  1973-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(73)91219-1PMID 4118538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Motilin, a gastric motor activity-stimulating polypeptide: final purification, amino acid composition, and C-terminal residues.

  1972cited by this paper
• Factors controlling colonic motility: Colonic pressures and transit after meals in patients with total gastrectomy, pernicious anaemia, or duodenal ulcer

  1970cited by this paper
• Observations on the mechanism of abdominal pain.

  1969cited by this paper
• Gastrointestinal motility and gastric secretion during intravenous infusions of gastrin II

  1969cited by this paper
• Motility of the pelvic colon

  1965cited by this paper
• Motility of the pelvic colon: Part IV Abdominal pain associated with colonic hypermotility after meals

  1965cited by this paper
• Comparison of cardiac and pyloric sphincters; a manometric study.

  1957cited by this paper
• Civilian Dyspepsia

  1945cited by this paper

• Use of endoscopic gallbladder stenting and biliary scintigraphy for diagnosis of gallbladder dyskinesia: a case report

  2023cites this paper
• A major mechanism for immunomodulation: Dietary fibres and acid metabolites.

  2023cites this paper
• The critical role of CCK in the regulation of food intake and diet-induced obesity.

  2021cites this paper
• Optimal hepatobiliary scintigraphy for gallbladder dyskinesia☆

  2020cites this paper
• Unique Gene Expression Signatures in the Intestinal Mucosa and Organoids Derived from Germ-Free and Monoassociated Mice

  2019cites this paper
• Fructose malabsorption induces cholecystokinin expression in the ileum and cecum by changing microbiota composition and metabolism

  2019cites this paper
• A new understanding of the physiology and pathophysiology of colonic motility?

  2018cites this paper
• CALIDAD DE VIDA EN LOS TRASTORNOS FUNCIONALES DIGESTIVOS

  2016cites this paper
• Postcholecystectomy Syndrome: From Pathophysiology to Differential Diagnosis - A Critical Review

  2015cites this paper
• Association Between SLC6A4 Serotonin Transporter Gene Lainked Polymorphic Region and ADRA2A −1291C>G and Irritable Bowel Syndrome in Korea

  2014cites this paper
• Increased Incidence of Bowel and Psychological Symptoms in Chinese Female D-IBS Patients With Premenstrual Syndrome

  2014cites this paper
• Effect of cholecystokinin on rectal motor and sensory function in patients with irritable bowel syndrome and healthy controls

  2013cites this paper
• Human chorionic gonadotropin regulates gastric emptying in ovariectomized rats.

  2013cites this paper
• Chapter 92 – Irritable Bowel Syndrome

  2013cites this paper
• Efficacy of carbon dioxide‐insufflating colonoscopy in patients with irritable bowel syndrome: A randomized double‐blind study

  2012cites this paper
• Normokinetic biliary dyskinesia: a novel diagnosis

  2012cites this paper
• Constipation-Predominant Irritable Bowel Syndrome Associated to Hyperprolactinemia

  2011cites this paper
• Mechanism of Action of Cholecystokinin on Colonic Motility in Isolated, Vascularly Perfused Rat Colon

  2011cites this paper
• Association of CCK1 Receptor Gene Polymorphisms and Irritable Bowel Syndrome in Korean

  2010influential citation
• Emerging drugs for irritable bowel syndrome

  2009cites this paper
• ANTIDIARRHEAL AND ANTISPASMODIC ACTIVITY OF WRIGHTIA TINCTORIA BARK AND ITS STEROIDAL ALKALOID FRACTION

  2009cites this paper
• Relationship between subtypes of irritable bowel syndrome and severity of symptoms associated with panic disorder

  2008cites this paper
• Enterochromaffin Cell Hyperplasia in Irritable Pouch Syndrome

  2008cites this paper
• Structural basis of cholecystokinin receptor binding and regulation.

  2008cites this paper
• mechanisms and practical management Guidelines on the irritable bowel syndrome

  2008cites this paper
• [Diagnostic endoscopic assessment of the irritable colon syndrome (author's transl)].

  2008cites this paper
• Guidelines on the irritable bowel syndrome: mechanisms and practical management

  2007cites this paper
• Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

  2007cites this paper
• The role of (99m)technetium-labelled hepato imino diacetic acid (HIDA) scan in the management of biliary pain.

  2007cites this paper
• Progress report The irritable bowel

  2006cites this paper
• CCK1 Antagonists: Are They Ready for Clinical Use?

  2006cites this paper
• Ultrasonographic evaluation of gallbladder functions in patients with irritable bowel syndrome

  2006cites this paper
• Hepatobiliary Disease : hronic Acalculous Gallbladder nd Chronic Acalculous Biliary Disease

  2006cites this paper
• INTESTINAL EN RATAS CON HIPERSENSIBILIDAD Y MECANISMOS NEUROENDOCRINOS REGULADORES DE LA FUNCIÓN MASTOCITARIA

  2005cites this paper
• Functional diarrhoea

  2005cites this paper
• Assessment of gallbladder function using ceruletide in oral cholecystography

  2005cites this paper
• Effect of CCK-1 Antagonist, Dexloxiglumide, in Female Patients with Irritable Bowel Syndrome: A Pharmacodynamic and Pharmacogenomic Study

  2005cites this paper
• Irritable bowel syndrome

  2005cites this paper
• Hypersensitivity to ovalbumin induces chronic intestinal dysmotility and increases the number of intestinal mast cells

  2005cites this paper
• Actividad de los mastocitos de la mucosa intestinal en ratas con hipersensibilidad y mecanismos neuroendocrinos reguladores de la función mastocitaria

  2005cites this paper
• Proctalgia fugax

  2005cites this paper
• Bile duct measurements after ceruletide as an aid to the ultrasound diagnosis of choledocholithiasis

  2005cites this paper
• Abnormal gallbladder motility in patients with irritable bowel syndrome

  2005influential citation
• Effect of sleep quality on symptoms of irritable bowel syndrome

  2005cites this paper
• Hypnosis and Irritable Bowel Syndrome: A Review of Efficacy and Mechanism of Action

  2005cites this paper
• [Spectral analysis of the electrical activity of the left colon].

  2004cites this paper
• Reduction by cimetropium bromide of the colonic motor response to eating in patients with the irritable bowel syndrome

  2004cites this paper
• Inhibition of postprandial colonic motility by sulpiride in patients with irritable colon

  2004cites this paper
• Review article: the overlap between functional dyspepsia and irritable bowel syndrome — a tale of one or two disorders?

  2004cites this paper
• Involvement of endogenous CCK and CCK1 receptors in colonic motor function

  2004cites this paper
• Effect of Cholecystokinin Octapeptide and Atropine on Human Colonic Motility, Tone, and Transit

  2004influential citation
• Inducible Nitric Oxide Synthase Inhibitors Ameliorate Hypermotility Observed After T. spiralis Infection in the Rat

  2003cites this paper
• Exercise and gastrointestinal function and disease: an evidence-based review of risks and benefits.

  2003cites this paper
• Gallbladder ejection fraction: an accurate evaluation of symptomatic acalculous gallbladder disease.

  2003cites this paper
• Antinerve Growth Factor Treatment Prevents Intestinal Dysmotility in Trichinella spiralis-Infected Rats

  2002influential citation
• Cholecystokinin octapeptide increases rectal sensitivity to pain in healthy subjects

  2002cites this paper
• Persistence of Abdominal Symptoms After Successful Surgery for Idiopathic Slow Transit Constipation

  2002cites this paper
• Cholecystokinin cholescintigraphy: clinical indications and proper methodology.

  2001cites this paper
• Alterations of intestinal motor responses to various stimuli after Nippostrongylus brasiliensis infection in rats: role of mast cells

  2000cites this paper
• 87 – Irritable Bowel Syndrome

  2000cites this paper
• Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis.

  2000cites this paper
• Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea

  2000cites this paper
• CCK A Receptors in Gastrointestinal Disorders

  2000cites this paper
• In vivo changes in the intestinal reflexes and the response to CCK in the inflamed small intestine of the rat.

  2000cites this paper
• Increased mast cells in the irritable bowel syndrome

  2000cites this paper
• [Colonic motility in humans. Recent physiological, pathophysiological and pharmacological data].

  2000cites this paper
• La motricité colique chez l'homme : Données récentes physiologiques, physiopathologiques et pharmacologiques

  2000cites this paper
• Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea

  2000cites this paper
• Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.

  1999cites this paper
• Abnormal electroencephalogram in irritable bowel syndrome.

  1999cites this paper
• Cholecystokinin cholescintigraphy: victim of its own success?

  1999cites this paper
• Psychosocial aspects of the functional gastrointestinal disorders.

  1999cites this paper
• Regional effects of cholecystokinin octapeptide on colonic phasic and tonic motility in healthy humans.

  1999cites this paper
• Chronic Acalculous Cholecystitis: Changes in Patient Demographics and Evaluation Since the Advent of Laparoscopy

  1999cites this paper
• Regional effects of cholecystokinin octapeptide on colonic phasic and tonic motility in healthy humans.

  1999cites this paper
• Constipation, diarrhea, and irritable bowel syndrome.

  1999cites this paper
• Gastrin, Cholecystokinin, and Somatostatin in a Laboratory Experiment of Patients With Functional Dyspepsia

  1998cites this paper
• A requiem for the cholecystokinin provocation test?

  1998cites this paper
• Dietary triggers in irritable bowel syndrome

  1998cites this paper
• Evidence of a Genetic Contribution to Functional Bowel Disorder

  1998cites this paper
• Bran: may irritate irritable bowel.

  1998cites this paper
• Irritable bowel syndrome. Streamlining the diagnosis.

  1997cites this paper
• Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disorders.

  1997cites this paper
• Biliary motility disorders.

  1997cites this paper
• Motility in irritable-bowel syndrome.

  1997cites this paper
• The irritable bowel syndrome.

  1997cites this paper
• Irritable bowel syndrome: a technical review for practice guideline development.

  1997cites this paper
• A Biopsychosocial Understanding of the Irritable Bowel Syndrome: A Review

  1997cites this paper
• Newer aspects of the irritable bowel syndrome.

  1996cites this paper
• [Recent psychosomatic contributions to the pathogenesis and therapy of irritable colon (irritable bowel syndrome)].

  1996cites this paper
• Plasma neurotransmitters and functional illness.

  1996cites this paper
• Chronic acalculous cholecystitis: laparoscopic treatment.

  1996cites this paper
• Physiological effect of cholecystokinin on gastric emptying of liquid in functional dyspepsia.

  1995cites this paper
• Effects of CCK‐receptor antagonist on colonic motor activity in dogs

  1995cites this paper
• Neuroendocrine disorders of the gut.

  1995cites this paper
• Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients.

  1994cites this paper
• Loxiglumide, a CCK‐A Antagonist, in Irritable Bowel Syndrome

  1994cites this paper
• Irritable bowel syndrome. Strategy for the family physician.

  1994cites this paper
• Effect of Cholecystokinin on Gastric Motility in Humans a

  1994cites this paper
• Colonic contractions and diverticular disease

  1994cites this paper